Tuberculosis: trials for referral
233 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
233 trials shown
Phase 21 site
Not yet recruitingPeru
NCT07656012
Re-evaluating the Duration in Children of TB Treatment
University of Wisconsin, Madison
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 1/211 sites
RecruitingBotswana, Haiti, Kenya, Thailand, Uganda, Zimbabwe
NCT07124559
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
National Institute of Allergy and Infectious Diseases (NIAID)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govNo phase3 sites
RecruitingMexico, United States
NCT04052022
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 216 sites
RecruitingSouth Africa
NCT05947890
Evaluating the Safety and Immunogenicity of MTBVAC
HIV Vaccine Trials Network
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govNo phase8 sites
RecruitingGabon
NCT07017803
Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
Centre de Recherche Médicale de Lambaréné
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited States
NCT01212003
Training Protocol on the Natural History of Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govNo phase2 sites
RecruitingKenya
NCT07901387
Biomarker Analysis for Diagnosing and Treatment Monitoring in Extrapulmonary Tuberculosis Patients in Nairobi, Kenya
Nagasaki University
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govNo phase2 sites
By invitation onlyPakistan
NCT06984887
Evaluation of New TB Diagnostic Tests (NATs) in Pakistan
Mercy Corps Pakistan
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govPhase 342 sites
RecruitingChina, Georgia, Indonesia, India, Japan, South Korea
NCT07209761
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 34 sites
RecruitingPakistan, South Africa, Zimbabwe
NCT07163143
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
University College, London
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 213 sites
RecruitingChina
NCT07893444
BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children
Huashan Hospital
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govNo phase5 sites
RecruitingSouth Africa
NCT05671718
Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
Johns Hopkins University
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited Kingdom
NCT06670755
ID93/GLA-SE Vaccination + BCG Challenge
University of Oxford
Registry updated 22 Oct 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingSouth Africa
NCT07883226
A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11
Gates Medical Research Institute
Registry updated 22 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingIndonesia
NCT07887724
Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis
DINA KEUMALA SARI
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govEarly Phase 11 site
Not yet recruitingEgypt
NCT07875322
Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury.
Assiut University
Registry updated 21 Oct 2026
Registry record: ClinicalTrials.govPhase 2/38 sites
RecruitingMongolia, Peru, Tanzania, Uganda
NCT06568484
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Johns Hopkins University
Registry updated 20 Oct 2026
Registry record: ClinicalTrials.govPhase 22 sites
RecruitingUganda
NCT07227779
BPaLMZ for TB Meningitis
David Boulware
Registry updated 16 Oct 2026
Registry record: ClinicalTrials.govPhase 211 sites
RecruitingMoldova, Tanzania, Uganda, Vietnam, South Africa
NCT06114628
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
University College, London
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.govNo phase3 sites
RecruitingMozambique, Uganda, South Africa
NCT05989802
Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)
University of California, San Francisco
Registry updated 15 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingBolivia
NCT06113861
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Tulane University
Registry updated 13 Oct 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingSpain
2026-525790-39-00
A study to investigate the repeat-dose pharmacokinetics of a combined oral contraceptive when given alone and in combination with ganfeborole in female participants of non-childbearing potential.
Glaxosmithkline Research & Development Limited
Registry updated 7 Oct 2026
Registry record: EU CTISPhase 11 site
RecruitingSpain
NCT07784894
A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential
GlaxoSmithKline
Registry updated 2 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited States
NCT07737275
Screening With Portable X-rays for Rapid Recognition of TB
Columbia University
Registry updated 2 Oct 2026
Registry record: ClinicalTrials.govNo phase16 sites
By invitation onlySouth Africa
NCT06314386
Systems Analysis and Improvement Approach to Prevent TB
Boston College
Registry updated 1 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingIndonesia
NCT07293455
Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia
Universitas Padjadjaran
Registry updated 25 Sept 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingSouth Africa
NCT07773610
Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis
TASK Applied Science
Pre-treatment window Registry sentence: “Newly diagnosed and untreated for this episode of TB.”
Registry updated 25 Sept 2026
Registry record: ClinicalTrials.govNo phase2 sites
Not yet recruitingUganda
NCT07840651
Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda
Makerere University
Registry updated 25 Sept 2026
Registry record: ClinicalTrials.govNo phase14 sites
RecruitingEthiopia
NCT07313995
Digital Health Intervention to Improve TPT Uptake
Arba Minch University
Registry updated 25 Sept 2026
Registry record: ClinicalTrials.govPhase 40 sites
Not yet recruiting
NCT07631377
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
Johns Hopkins University
Registry updated 23 Sept 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- South Africa34 open trials
- China30 open trials
- Uganda23 open trials
- Vietnam11 open trials
- Indonesia10 open trials
- India10 open trials
- Tanzania10 open trials
- Peru8 open trials
- United States8 open trials
- France8 open trials
- Italy8 open trials
- Kenya7 open trials
- United Kingdom7 open trials
- Zambia7 open trials
- Brazil7 open trials
- Nigeria7 open trials
- South Korea6 open trials
- Spain6 open trials
- Ethiopia6 open trials
- Hong Kong SAR China6 open trials
- Thailand5 open trials
- Zimbabwe5 open trials
- Philippines5 open trials
- Mozambique5 open trials
- Germany5 open trials
- Pakistan4 open trials
- Netherlands4 open trials
- Haiti3 open trials
- Mexico3 open trials
- Moldova3 open trials
- Egypt3 open trials
- Malawi3 open trials
- Taiwan3 open trials
- Sweden3 open trials
- Botswana2 open trials
- Gabon2 open trials
- Georgia2 open trials
- Mongolia2 open trials
- Australia2 open trials
- Malaysia2 open trials
- Singapore2 open trials
- Canada2 open trials
- Benin2 open trials
- Guinea-Bissau2 open trials
- Japan1 open trials
- Bolivia1 open trials
- Ukraine1 open trials
- Greece1 open trials
- Argentina1 open trials
- Denmark1 open trials
- Tajikistan1 open trials
- Côte d’Ivoire1 open trials
- Madagascar1 open trials
- Cameroon1 open trials
- Guinea1 open trials
- Paraguay1 open trials
- Saudi Arabia1 open trials
- Chile1 open trials
- Niger1 open trials
- Romania1 open trials
- Bangladesh1 open trials
- Switzerland1 open trials
- Austria1 open trials
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Madrid, Spain
0 trials · 83 publications · ROR
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
Madrid, Spain
0 trials · 72 publications · ROR
Centro de Investigación Biomédica en Red Enfermedades Infecciosas
Madrid, Spain
0 trials · 87 publications · ROR
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
0 trials · 161 publications · ROR
Consejo Nacional de Investigaciones Científicas y Técnicas
Buenos Aires, Argentina
0 trials · 77 publications · ROR
Dr. D. Y. Patil Medical College, Hospital and Research Centre
Pune, India
1 trials · 86 publications · ROR
Institut de Pharmacologie et de Biologie Structurale
Toulouse, France
0 trials · 70 publications · ROR
Institute of Infectious Disease and Molecular Medicine
Cape Town, South Africa
0 trials · 219 publications · ROR
Jawaharlal Institute of Post Graduate Medical Education and Research
Puducherry, India
0 trials · 81 publications · ROR
National Institute of Allergy and Infectious Diseases
Bethesda, United States
0 trials · 167 publications · ROR
Post Graduate Institute of Medical Education and Research
Chandigarh, India
1 trials · 139 publications · ROR
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
Jakarta, Indonesia
0 trials · 79 publications · ROR
Russian Medical Academy of Continuous Professional Education
Moscow, Russia
0 trials · 85 publications · ROR
Rutgers, The State University of New Jersey
New Brunswick, United States
1 trials · 91 publications · ROR
South African Tuberculosis Vaccine Initiative
Cape Town, South Africa
2 trials · 78 publications · ROR
University of California, San Francisco
San Francisco, United States
0 trials · 332 publications · ROR
University of Massachusetts Chan Medical School
Worcester, United States
0 trials · 90 publications · ROR
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 trials · 84 publications · ROR
Wellcome Centre for Infectious Diseases Research in Africa
Cape Town, South Africa
1 trials · 92 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
No registry change in the last 7 days.
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
Phase 1Ended 31 Oct 2026
Completed60 participants
NCT07069582
Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women
Phase 3Ended 30 Sept 2026
Completed414 participants
NCT05575518
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
Phase 4Ended 20 Sept 2026
Completed75 participants
2025-522235-34-00
Clinical trial in multiple hospitals to explore new ways to diagnose and monitor tuberculosis treatment
No phaseEnded 28 Aug 2026
Completed32 participants
NCT07899138
Effect of Vitamin D and Zinc Supplementation on Inflammatory Biomarkers in Pulmonary Tuberculosis Patients
No phaseEnded 10 Aug 2026
Completed311 participants
NCT06737029
Alternative Diagnoses in Patients About to Start Empiric Tuberculosis Treatment
No phaseEnded 31 Jul 2026
Completed81 participants
NCT07069387
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
No phaseEnded 30 Jul 2026
No phaseEnded 27 Jul 2026
No phaseEnded 31 May 2026
Completed23 participants
NCT07451899
TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease
No phaseEnded 30 Apr 2026
Completed1185 participants
NCT07608601
Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu Nice
No phaseEnded 30 Apr 2026
Completed200 participants
NCT04926922
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
Phase 1Ended 28 Apr 2026
Completed32 participants
NCT05586230
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Phase 1Ended 27 Apr 2026
No phaseEnded 17 Apr 2026
Completed550 participants
NCT05047055
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients
Phase 4Ended 23 Mar 2026
Completed225 participants
2023-506432-32-00
Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease.
Phase 1Ended 12 Mar 2026
Completed32 participants
2025-521502-18-00
A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function
No phaseEnded 11 Mar 2026
Completed626 participants
NCT04526613
The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
No phaseEnded 28 Feb 2026
No phaseEnded 30 Jan 2026
Phase 2Ended 13 Jan 2026
Phase 1Ended 11 Jan 2026
Completed36 participants
NCT07094932
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
No phaseEnded 8 Jan 2026
Completed1377 participants
NCT03733093
PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)
No phaseEnded 7 Jan 2026
Completed7455 participants
NCT05581212
TB Case-Finding, Treatment and Prevention Intervention in Thailand
No phaseEnded 31 Dec 2025
No phaseEnded 31 Dec 2025
Completed9097 participants
NCT04752592
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
No phaseEnded 30 Dec 2025
Completed32 participants
NCT07907094
Vitamin D3 and Monocyte Responses in Pregnant Women With Pulmonary Tuberculosis
No phaseEnded 30 Dec 2025
No phaseEnded 29 Dec 2025
Phase 1Ended 8 Dec 2025
Completed120 participants
NCT05537038
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
No phaseEnded 1 Dec 2025
Completed89 participants
NCT05621343
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
Phase 3Ended 12 Nov 2025
Completed1330 participants
NCT04738812
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
Phase 2Ended 12 Nov 2025
Completed30 participants
NCT05630872
Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis
No phaseEnded 6 Nov 2025
Completed112 participants
NCT06054334
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Phase 2Ended 31 Oct 2025
Completed44 participants
2025-520745-80-00
A randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis (DRTB-HDT).
No phaseEnded 28 Oct 2025
Completed10 participants
NCT05609552
Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
No phaseEnded 25 Oct 2025
Completed60 participants
NCT04844502
Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis
Phase 3Ended 22 Sept 2025
Completed780 participants
NCT05899179
Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
No phaseEnded 21 Sept 2025
No phaseEnded 31 Aug 2025
Completed350 participants
NCT07167823
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
No phaseEnded 21 Aug 2025
Completed300 participants
NCT07587164
C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia
Phase 2Ended 15 Aug 2025
Completed112 participants
NCT04930744
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis. · Antimicrobial agents and chemotherapy, 2026
No phaseEnded 4 Aug 2025
Completed301 participants
NCT06214910
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
No phaseEnded 31 Jul 2025
Completed213 participants
NCT03800407
Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection
No phaseEnded 31 Jul 2025
Completed332 participants
NCT04308928
Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis
No phaseEnded 31 Jul 2025
Completed43067 participants
NCT06702774
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
No phaseEnded 21 Jul 2025
Completed141 participants
NCT05048485
Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
No phaseEnded 21 Jul 2025
Completed364 participants
NCT06739915
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa
No phaseEnded 15 Jul 2025
No phaseEnded 4 Jul 2025
Completed125 participants
NCT04968886
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
No phaseEnded 30 Jun 2025
No phaseEnded 30 Jun 2025
Completed1967 participants
NCT05047315
Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV
Phase 1Ended 25 Jun 2025
Completed78 participants
NCT05413551
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Phase 2Ended 19 Jun 2025
Completed140 participants
NCT04919239
Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)
No phaseEnded 1 Jun 2025
No phaseEnded 1 Jun 2025
Completed118 participants
NCT05739695
A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions
No phaseEnded 1 Jun 2025
Phase 1/2Ended 29 May 2025
Phase 2Ended 27 May 2025
No phaseEnded 21 May 2025
Phase 3Ended 20 May 2025
Completed437 participants
NCT04618198
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Not medical advice. fetched 4 Nov 2026